Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05611346

HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers

HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers : Study Protocol of a Pilot Randomized and Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Academic / Other
Sex
All
Age
8 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHypnosisThe experimental group will receive 2 standardized hypnosis sessions via the "superhero costume" technique performed during this collective therapeutic education program, completed by a reinforcement through the practice of self-hypnosis at home guided by the listening of an audio recording

Timeline

Start date
2024-08-13
Primary completion
2027-02-01
Completion
2027-12-01
First posted
2022-11-10
Last updated
2025-09-12

Locations

1 site across 1 country: Reunion

Source: ClinicalTrials.gov record NCT05611346. Inclusion in this directory is not an endorsement.